The human milk oligosaccharide 3’sialyllactose promotes inflammation resolution and reduces atherosclerosis development.

A. Pessentheiner; N. Spann; C. Collins; B. Ramms; A. Chiang; Y. Wang; A. Quach; L. Booshehri; A. Hammond; C. Tognaccini; J. Latasiewicz; J.L. Witztum; H. Hoffman; N. Lewis; C. Glass; L. Bode; P. Gordts

doi:10.1016/j.atherosclerosis.2021.06.089

The human milk oligosaccharide 3’sialyllactose promotes inflammation resolution and reduces atherosclerosis development.

A. Pessentheiner
, N. Spann
, C. Collins
, B. Ramms
, A. Chiang
, Y. Wang
, A. Quach
, L. Booshehri
, A. Hammond
, C. Tognaccini
, J. Latasiewicz
, J.L. Witztum
, H. Hoffman
, N. Lewis
, C. Glass
, L. Bode
, P. Gordts

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Journal	Atherosclerosis
DOIs	https://doi.org/10.1016/j.atherosclerosis.2021.06.089
State	Published - Aug 2021

Access to Document

10.1016/j.atherosclerosis.2021.06.089

Cite this

Pessentheiner, A., Spann, N., Collins, C., Ramms, B., Chiang, A., Wang, Y., Quach, A., Booshehri, L., Hammond, A., Tognaccini, C., Latasiewicz, J., Witztum, J. L., Hoffman, H., Lewis, N., Glass, C., Bode, L., & Gordts, P. (2021). The human milk oligosaccharide 3’sialyllactose promotes inflammation resolution and reduces atherosclerosis development. Atherosclerosis. https://doi.org/10.1016/j.atherosclerosis.2021.06.089

Pessentheiner, A, Spann, N, Collins, C, Ramms, B, Chiang, A , Wang, Y, Quach, A, Booshehri, L, Hammond, A, Tognaccini, C, Latasiewicz, J, Witztum, JL, Hoffman, H, Lewis, N, Glass, C, Bode, L & Gordts, P 2021, 'The human milk oligosaccharide 3’sialyllactose promotes inflammation resolution and reduces atherosclerosis development.', Atherosclerosis. https://doi.org/10.1016/j.atherosclerosis.2021.06.089

@article{dd702f6d4a2c4e2b91ec8a76e5a92f80,

title = "The human milk oligosaccharide 3{\textquoteright}sialyllactose promotes inflammation resolution and reduces atherosclerosis development.",

author = "A. Pessentheiner and N. Spann and C. Collins and B. Ramms and A. Chiang and Y. Wang and A. Quach and L. Booshehri and A. Hammond and C. Tognaccini and J. Latasiewicz and J.L. Witztum and H. Hoffman and N. Lewis and C. Glass and L. Bode and P. Gordts",

year = "2021",

month = aug,

doi = "10.1016/j.atherosclerosis.2021.06.089",

language = "English (US)",

journal = "Atherosclerosis",

issn = "0021-9150",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - The human milk oligosaccharide 3’sialyllactose promotes inflammation resolution and reduces atherosclerosis development.

AU - Pessentheiner, A.

AU - Spann, N.

AU - Collins, C.

AU - Ramms, B.

AU - Chiang, A.

AU - Wang, Y.

AU - Quach, A.

AU - Booshehri, L.

AU - Hammond, A.

AU - Tognaccini, C.

AU - Latasiewicz, J.

AU - Witztum, J.L.

AU - Hoffman, H.

AU - Lewis, N.

AU - Glass, C.

AU - Bode, L.

AU - Gordts, P.

PY - 2021/8

Y1 - 2021/8

UR - http://dx.doi.org/10.1016/j.atherosclerosis.2021.06.089

U2 - 10.1016/j.atherosclerosis.2021.06.089

DO - 10.1016/j.atherosclerosis.2021.06.089

M3 - Article

SN - 0021-9150

JO - Atherosclerosis

JF - Atherosclerosis

ER -

The human milk oligosaccharide 3’sialyllactose promotes inflammation resolution and reduces atherosclerosis development.

Access to Document

Other files and links

Cite this